TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs10022787
log Bayes Factor = 8.05101
Chromosome 4   position 56,521,889  (GRCh37) Explore rs10022787 on Ensembl!
Variant rs10022787 is part of Cluster X0076

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites
1.000 0.000 0.000
Chapter II Neoplasms
1.000 0.000 0.000
# Top node
1.000 0.000 0.000
Chapter XXI Factors influencing health status and contact with health services
1.000 0.000 0.000
C79 Secondary malignant neoplasm of other sites
1.000 0.000 0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs
0.999 0.001 0.000
Z51 Other medical care
0.998 0.002 0.000
Z51.1 Chemotherapy session for neoplasm
0.997 0.003 0.000
Z20-Z29 Persons with potential health hazards related to communicable diseases
0.995 0.005 0.000
Z40-Z54 Persons encountering health services for specific procedures and health care
0.995 0.005 0.000
Z51.5 Palliative care
0.993 0.007 0.000
Chapter I Certain infectious and parasitic diseases
0.992 0.008 0.000
C78.7 Secondary malignant neoplasm of liver
0.989 0.011 0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow
0.987 0.013 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.983 0.017 0.000
D37-D48 Neoplasms of uncertain or unknown behaviour
0.978 0.022 0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
0.978 0.022 0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities
0.978 0.022 0.000
Z51.3 Blood transfusion without reported diagnosis
0.972 0.028 0.000
Z70-Z76 Persons encountering health services in other circumstances
0.966 0.034 0.000
Z22 Carrier of infectious disease
0.964 0.036 0.000
D80-D89 Certain disorders involving the immune mechanism
0.961 0.039 0.000
Z29 Need for other prophylactic measures
0.959 0.041 0.000
C79.8 Secondary malignant neoplasm of other specified sites
0.957 0.043 0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs
0.951 0.049 0.000
A00-A09 Intestinal infectious diseases
0.950 0.050 0.000
D86 Sarcoidosis
0.946 0.054 0.000
Z22.3 Carrier of other specified bacterial diseases
0.942 0.058 0.000
C78.0 Secondary malignant neoplasm of lung
0.941 0.059 0.000
C79.7 Secondary malignant neoplasm of adrenal gland
0.938 0.062 0.000
Chapter XX External causes of morbidity and mortality
0.935 0.065 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.934 0.066 0.000
D70-D77 Other diseases of blood and blood-forming organs
0.920 0.080 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.919 0.081 0.000
Chapter VIII Diseases of the ear and mastoid process
0.918 0.082 0.000
Q50-Q56 Congenital malformations of genital organs
0.914 0.086 0.000
Z30-Z39 Persons encountering health services in circumstances related to reproduction
0.913 0.087 0.000
C78.1 Secondary malignant neoplasm of mediastinum
0.910 0.089 0.000
Z75 Problems related to medical facilities and other health care
0.905 0.095 0.000
B35-B49 Mycoses
0.904 0.096 0.000
Z45 Adjustment and management of implanted device
0.902 0.098 0.000
D70 Agranulocytosis
0.901 0.099 0.000
D86.9 Sarcoidosis, unspecified
0.901 0.099 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.894 0.106 0.000
Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified
0.893 0.107 0.000
A30-A49 Other bacterial diseases
0.893 0.107 0.000
A04 Other bacterial intestinal infections
0.892 0.108 0.000
H65-H75 Diseases of middle ear and mastoid
0.886 0.114 0.000
C79.9 Secondary malignant neoplasm, unspecified site
0.882 0.118 0.000
C90.0 Multiple myeloma
0.879 0.121 0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.876 0.124 0.000
Z45.2 Adjustment and management of vascular access device
0.876 0.124 0.000
H66 Suppurative and unspecified otitis media
0.875 0.125 0.000
Z75.1 Person awaiting admission to adequate facility elsewhere
0.871 0.129 0.000
Chapter XXII Codes for special purposes
0.870 0.130 0.000
Z40 Prophylactic surgery
0.868 0.132 0.000
A09 Diarrhoea and gastro-enteritis of presumed infectious origin
0.864 0.136 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.862 0.138 0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs
0.862 0.138 0.000
Z32 Pregnancy examination and test
0.859 0.141 0.000
A49 Bacterial infection of unspecified site
0.857 0.143 0.000
C34 Malignant neoplasm of bronchus and lung
0.857 0.143 0.000
Z29.2 Other prophylactic chemotherapy
0.855 0.145 0.000
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments
0.853 0.147 0.000
B37 Candidiasis
0.853 0.147 0.000
Chapter VII Diseases of the eye and adnexa
0.852 0.148 0.000
Z51.2 Other chemotherapy
0.851 0.149 0.000
Z29.0 Isolation
0.847 0.153 0.000
A04.7 Enterocolitis due to Clostridium difficile
0.846 0.154 0.000
H40-H42 Glaucoma
0.845 0.155 0.000
Z73 Problems related to life-management difficulty
0.843 0.157 0.000
C32 Malignant neoplasm of larynx
0.843 0.157 0.000
W00-W19 Falls
0.842 0.158 0.000
Z71.1 Person with feared complaint in whom no diagnosis is made
0.840 0.160 0.000
H40 Glaucoma
0.840 0.160 0.000
D86.0 Sarcoidosis of lung
0.839 0.161 0.000
C85.1 B-cell lymphoma, unspecified
0.836 0.164 0.000
Y43 Primarily systemic agents
0.835 0.165 0.000
B37.0 Candidal stomatitis
0.834 0.166 0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites
0.831 0.169 0.000
H40.1 Primary open-angle glaucoma
0.823 0.177 0.000
A15-A19 Tuberculosis
0.820 0.180 0.000
A09.9 Gastroenteritis and colitis of unspecified origin
0.817 0.183 0.000
H66.3 Other chronic suppurative otitis media
0.816 0.184 0.000
H66.9 Otitis media, unspecified
0.815 0.185 0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs
0.814 0.186 0.000
H40.9 Glaucoma, unspecified
0.812 0.188 0.000
Q50.4 Embryonic cyst of Fallopian tube
0.810 0.190 0.000
B65-B83 Helminthiases
0.809 0.191 0.000
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system
0.806 0.194 0.000
Z35 Supervision of high-risk pregnancy
0.805 0.195 0.000
H60-H62 Diseases of external ear
0.804 0.196 0.000
Y43.3 Other antineoplastic drugs
0.803 0.197 0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.803 0.197 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.801 0.199 0.000
X40-X49 Accidental poisoning by and exposure to noxious substances
0.797 0.203 0.000
C34.1 Upper lobe, bronchus or lung
0.796 0.204 0.000
D00-D09 In situ neoplasms
0.795 0.205 0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
0.793 0.207 0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum
0.792 0.208 0.000
A49.0 Staphylococcal infection, unspecified
0.791 0.209 0.000
D86.8 Sarcoidosis of other and combined sites
0.785 0.215 0.000
H74 Other disorders of middle ear and mastoid
0.785 0.215 0.000
Q20-Q28 Congenital malformations of the circulatory system
0.782 0.218 0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use
0.781 0.219 0.000
Z71.9 Counselling, unspecified
0.781 0.219 0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
0.781 0.219 0.000
Z40.0 Prophylactic surgery for risk-factors related to malignant neoplasms
0.779 0.221 0.000
C91 Lymphoid leukaemia
0.779 0.221 0.000
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands
0.775 0.225 0.000
D46 Myelodysplastic syndromes
0.773 0.227 0.000
Chapter XII Diseases of the skin and subcutaneous tissue
0.773 0.227 0.000
D47.2 Monoclonal gammopathy
0.772 0.228 0.000
C40-C41 Malignant neoplasms of bone and articular cartilage
0.771 0.229 0.000
Z34 Supervision of normal pregnancy
0.770 0.230 0.000
D45 Polycythaemia vera
0.768 0.232 0.000
Y45.0 Opioids and related analgesics
0.767 0.233 0.000
A50-A64 Infections with a predominantly sexual mode of transmission
0.766 0.233 0.000
Z32.1 Pregnancy confirmed
0.765 0.235 0.000
Q80-Q89 Other congenital malformations
0.763 0.237 0.000
Z32.0 Pregnancy, not (yet) confirmed
0.760 0.240 0.000
Z29.8 Other specified prophylactic measures
0.759 0.241 0.000
A04.9 Bacterial intestinal infection, unspecified
0.759 0.241 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.758 0.242 0.000
Z22.1 Carrier of other intestinal infectious diseases
0.757 0.243 0.000
Z21 Asymptomatic human immunodeficiency virus [HIV] infection status
0.755 0.245 0.000
H60 Otitis externa
0.754 0.246 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.754 0.246 0.000
H70 Mastoiditis and related conditions
0.754 0.246 0.000
Q90-Q99 Chromosomal abnormalities, not elsewhere classified
0.752 0.248 0.000
D05 Carcinoma in situ of breast
0.752 0.248 0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites
0.750 0.250 0.000
C88 Malignant immunoproliferative diseases
0.749 0.250 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.749 0.251 0.000
A49.1 Streptococcal infection, unspecified
0.742 0.258 0.000
Z29.1 Prophylactic immunotherapy
0.741 0.258 0.000
D48.6 Breast
0.739 0.261 0.000
A80-A89 Viral infections of the central nervous system
0.739 0.261 0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.738 0.262 0.000
Q60-Q64 Congenital malformations of the urinary system
0.738 0.262 0.000
Q38-Q45 Other congenital malformations of the digestive system
0.737 0.263 0.000
Z43 Attention to artificial openings
0.737 0.263 0.000
A07 Other protozoal intestinal diseases
0.736 0.264 0.000
Chapter XV Pregnancy, childbirth and the puerperium
0.735 0.265 0.000
D48.0 Bone and articular cartilage
0.733 0.267 0.000
Z54 Convalescence
0.729 0.271 0.000
H66.4 Suppurative otitis media, unspecified
0.728 0.272 0.000
X58-X59 Accidental exposure to other and unspecified factors
0.728 0.272 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.728 0.272 0.000
Z73.3 Stress, not elsewhere classified
0.726 0.274 0.000
D55-D59 Haemolytic anaemias
0.725 0.275 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.722 0.278 0.000
U80 Agent resistant to penicillin and related antibiotics
0.722 0.278 0.000
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs
0.722 0.278 0.000
C60-C63 Malignant neoplasms of male genital organs
0.721 0.279 0.000
L80-L99 Other disorders of the skin and subcutaneous tissue
0.720 0.280 0.000
H43-H45 Disorders of vitreous body and globe
0.720 0.280 0.000
B50-B64 Protozoal diseases
0.720 0.280 0.000
C76 Malignant neoplasm of other and ill-defined sites
0.719 0.281 0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
0.719 0.281 0.000
C34.0 Main bronchus
0.718 0.282 0.000
Chapter XVI Certain conditions originating in the perinatal period
0.717 0.283 0.000
H55-H59 Other disorders of eye and adnexa
0.717 0.283 0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs
0.716 0.283 0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified
0.716 0.283 0.000
Z51.6 Desensitisation to allergens
0.716 0.284 0.000
C95 Leukaemia of unspecified cell type
0.716 0.284 0.000
D84 Other immunodeficiencies
0.714 0.286 0.000
C80 Malignant neoplasm without specification of site
0.714 0.286 0.000
Z28 Immunisation not carried out
0.713 0.286 0.000
Z27 Need for immunisation against combinations of infectious diseases
0.713 0.286 0.000
Z26 Need for immunisation against other single infectious diseases
0.713 0.286 0.000
Z25 Need for immunisation against other single viral diseases
0.713 0.286 0.000
Z24 Need for immunisation against certain single viral diseases
0.713 0.286 0.000
Z23 Need for immunisation against single bacterial diseases
0.713 0.286 0.000
Z20 Contact with and exposure to communicable diseases
0.713 0.286 0.000
Z33 Pregnant state, incidental
0.713 0.287 0.000
C79.6 Secondary malignant neoplasm of ovary
0.712 0.288 0.000
H60.9 Otitis externa, unspecified
0.712 0.288 0.000
B85-B89 Pediculosis, acariasis and other infestations
0.711 0.289 0.000
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers
0.711 0.289 0.000
A75-A79 Rickettsioses
0.711 0.289 0.000
A70-A74 Other diseases caused by chlamydiae
0.711 0.289 0.000
A65-A69 Other spirochaetal diseases
0.711 0.289 0.000
A20-A28 Certain zoonotic bacterial diseases
0.711 0.289 0.000
Y45.8 Other analgesics and antipyretics
0.711 0.289 0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs
0.711 0.289 0.000
Z76 Persons encountering health services in other circumstances
0.709 0.291 0.000
Z39 Postpartum care and examination
0.708 0.292 0.000
B37.2 Candidiasis of skin and nail
0.707 0.293 0.000
V80-V89 Other land transport accidents
0.706 0.294 0.000
C30 Malignant neoplasm of nasal cavity and middle ear
0.706 0.294 0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body
0.706 0.294 0.000
L89 Decubitus ulcer
0.706 0.294 0.000
Q51 Congenital malformations of uterus and cervix
0.706 0.294 0.000
B36 Other superficial mycoses
0.705 0.295 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.704 0.295 0.000
C94 Other leukaemias of specified cell type
0.704 0.295 0.000
C93 Monocytic leukaemia
0.704 0.295 0.000
C86 Other specified types of T/NK-cell lymphoma
0.704 0.295 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.704 0.295 0.000
D41 Neoplasm of uncertain or unknown behaviour of urinary organs
0.704 0.296 0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use
0.704 0.296 0.000
W19 Unspecified fall
0.703 0.297 0.000
C32.9 Larynx, unspecified
0.702 0.298 0.000
D42 Neoplasm of uncertain or unknown behaviour of meninges
0.701 0.299 0.000
Q35-Q37 Cleft lip and cleft palate
0.701 0.299 0.000
Q30-Q34 Congenital malformations of the respiratory system
0.701 0.299 0.000
C32.0 Glottis
0.700 0.300 0.000
C78.4 Secondary malignant neoplasm of small intestine
0.700 0.300 0.000
D05.9 Carcinoma in situ of breast, unspecified
0.700 0.300 0.000
B15-B19 Viral hepatitis
0.699 0.301 0.000
X60-X84 Intentional self-harm
0.698 0.302 0.000
D39.1 Ovary
0.697 0.303 0.000
A16 Respiratory tuberculosis, not confirmed bacteriologically or histologically
0.697 0.303 0.000
C12 Malignant neoplasm of pyriform sinus
0.697 0.303 0.000
Q53 Undescended testicle
0.696 0.304 0.000
C78.2 Secondary malignant neoplasm of pleura
0.696 0.304 0.000
A40 Streptococcal septicaemia
0.695 0.305 0.000
Z70 Counselling related to sexual attitude, behaviour and orientation
0.692 0.308 0.000
Z22.9 Carrier of infectious disease, unspecified
0.691 0.309 0.000
Z22.8 Carrier of other infectious diseases
0.691 0.309 0.000
Z22.6 Carrier of human T-lymphotropic virus type 1 [HTLV-1] infection
0.691 0.309 0.000
Z22.4 Carrier of infections with a predominantly sexual mode of transmission
0.691 0.309 0.000
Z22.2 Carrier of diphtheria
0.691 0.309 0.000
Z22.0 Carrier of typhoid
0.691 0.309 0.000
V40-V49 Car occupant injured in transport accident
0.690 0.310 0.000
Q10-Q18 Congenital malformations of eye, ear, face and neck
0.690 0.310 0.000
L82 Seborrhoeic keratosis
0.690 0.310 0.000
U80.1 Methicillin resistant agent
0.689 0.311 0.000
D83 Common variable immunodeficiency
0.689 0.311 0.000
D82 Immunodeficiency associated with other major defects
0.689 0.311 0.000
D81 Combined immunodeficiencies
0.689 0.311 0.000
Z34.9 Supervision of normal pregnancy, unspecified
0.689 0.311 0.000
Z44 Fitting and adjustment of external prosthetic device
0.688 0.312 0.000
W07 Fall involving chair
0.688 0.312 0.000
Z29.9 Prophylactic measure, unspecified
0.688 0.312 0.000
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs
0.688 0.312 0.000
B20-B24 Human immunodeficiency virus [HIV] disease
0.688 0.312 0.000
Z51.9 Medical care, unspecified
0.687 0.312 0.000
H72 Perforation of tympanic membrane
0.686 0.314 0.000
A49.9 Bacterial infection, unspecified
0.686 0.314 0.000
Z71.6 Tobacco abuse counselling
0.683 0.317 0.000
Y48 Anaesthetics and therapeutic gases
0.682 0.317 0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs
0.682 0.318 0.000
C38 Malignant neoplasm of heart, mediastinum and pleura
0.682 0.318 0.000
C31 Malignant neoplasm of accessory sinuses
0.682 0.318 0.000
C37 Malignant neoplasm of thymus
0.682 0.318 0.000
C33 Malignant neoplasm of trachea
0.682 0.318 0.000
A06 Amoebiasis
0.681 0.319 0.000
A05 Other bacterial foodborne intoxications
0.681 0.319 0.000
A03 Shigellosis
0.681 0.319 0.000
A01 Typhoid and paratyphoid fevers
0.681 0.319 0.000
A00 Cholera
0.681 0.319 0.000
D80 Immunodeficiency with predominantly antibody defects
0.680 0.320 0.000
Z48 Other surgical follow-up care
0.679 0.321 0.000
D86.3 Sarcoidosis of skin
0.678 0.322 0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes
0.678 0.322 0.000
D86.1 Sarcoidosis of lymph nodes
0.678 0.322 0.000
B80 Enterobiasis
0.678 0.322 0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands
0.676 0.324 0.000
Z35.2 Supervision of pregnancy with other poor reproductive or obstetric history
0.676 0.324 0.000
Z73.8 Other problems related to life-management difficulty
0.675 0.324 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.675 0.325 0.000
W20-W49 Exposure to inanimate mechanical forces
0.675 0.325 0.000
B99-B99 Other infectious diseases
0.672 0.328 0.000
D72 Other disorders of white blood cells
0.672 0.328 0.000
Y45.1 Salicylates
0.671 0.329 0.000
D47.1 Chronic myeloproliferative disease
0.671 0.329 0.000
Y35-Y36 Legal intervention and operations of war
0.671 0.329 0.000
Y10-Y34 Event of undetermined intent
0.671 0.329 0.000
X85-X99 Assault
0.671 0.329 0.000
X30-X39 Exposure to forces of nature
0.671 0.329 0.000
X00-X09 Exposure to smoke, fire and flames
0.671 0.329 0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure
0.671 0.329 0.000
W75-W84 Other accidental threats to breathing
0.671 0.329 0.000
W65-W74 Accidental drowning and submersion
0.671 0.329 0.000
V98-V99 Other and unspecified transport accidents
0.671 0.329 0.000
V95-V97 Air and space transport accidents
0.671 0.329 0.000
V90-V94 Water transport accidents
0.671 0.329 0.000
V70-V79 Bus occupant injured in transport accident
0.671 0.329 0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident
0.671 0.329 0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident
0.671 0.329 0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident
0.671 0.329 0.000
V01-V09 Pedestrian injured in transport accident
0.671 0.329 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.670 0.330 0.000
C85.0 Lymphosarcoma
0.670 0.330 0.000
A39 Meningococcal infection
0.668 0.332 0.000
L89.1 Stage II decubitus ulcer
0.667 0.333 0.000
X10-X19 Contact with heat and hot substances
0.666 0.334 0.000
C51-C58 Malignant neoplasms of female genital organs
0.665 0.335 0.000
X20-X29 Contact with venomous animals and plants
0.664 0.336 0.000
Y46.2 Hydantoin derivatives
0.663 0.337 0.000
Y60-Y69 Misadventures to patients during surgical and medical care
0.663 0.337 0.000
Q00-Q07 Congenital malformations of the nervous system
0.662 0.338 0.000
C15-C26 Malignant neoplasms of digestive organs
0.661 0.339 0.000
D74 Methaemoglobinaemia
0.660 0.340 0.000
D77 Other disorders of blood and blood-forming organs in diseases classified elsewhere
0.660 0.340 0.000
D71 Functional disorders of polymorphonuclear neutrophils
0.660 0.340 0.000
W08 Fall involving other furniture
0.659 0.341 0.000
H70.9 Mastoiditis, unspecified
0.659 0.341 0.000
C90.3 Solitary plasmacytoma
0.659 0.341 0.000
C90.1 Plasma cell leukaemia
0.659 0.341 0.000
Y00-Y09 Assault
0.658 0.342 0.000
Chapter VI Diseases of the nervous system
0.658 0.342 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.658 0.342 0.000
L83 Acanthosis nigricans
0.658 0.342 0.000
O00-O08 Pregnancy with abortive outcome
0.657 0.343 0.000
H74.1 Adhesive middle ear disease
0.656 0.344 0.000
Q56 Indeterminate sex and pseudohermaphroditism
0.655 0.345 0.000
Q55 Other congenital malformations of male genital organs
0.655 0.345 0.000
Q52 Other congenital malformations of female genitalia
0.655 0.345 0.000
H40.4 Glaucoma secondary to eye inflammation
0.655 0.345 0.000
Z38 Liveborn infants according to place of birth
0.654 0.346 0.000
V20-V29 Motorcycle rider injured in transport accident
0.654 0.346 0.000
C91.0 Acute lymphoblastic leukaemia
0.653 0.347 0.000
D47.3 Essential (haemorrhagic) thrombocythaemia
0.652 0.348 0.000
Z75.3 Unavailability and inaccessibility of health-care facilities
0.652 0.348 0.000
B25-B34 Other viral diseases
0.651 0.349 0.000
A46 Erysipelas
0.650 0.350 0.000
H43 Disorders of vitreous body
0.649 0.351 0.000
W18 Other fall on same level
0.649 0.351 0.000
H74.0 Tympanosclerosis
0.649 0.351 0.000
Z75.9 Unspecified problem related to medical facilities and other health care
0.648 0.351 0.000
Z75.8 Other problems related to medical facilities and other health care
0.648 0.351 0.000
Z75.4 Unavailability and inaccessibility of other helping agencies
0.648 0.351 0.000
Z75.2 Other waiting period for investigation and treatment
0.648 0.351 0.000
Z75.0 Medical services not available in home
0.648 0.351 0.000
B48 Other mycoses, not elsewhere classified
0.648 0.352 0.000
B47 Mycetoma
0.648 0.352 0.000
B46 Zygomycosis
0.648 0.352 0.000
B45 Cryptococcosis
0.648 0.352 0.000
B43 Chromomycosis and phaeomycotic abscess
0.648 0.352 0.000
B42 Sporotrichosis
0.648 0.352 0.000
B41 Paracoccidioidomycosis
0.648 0.352 0.000
B40 Blastomycosis
0.648 0.352 0.000
B39 Histoplasmosis
0.648 0.352 0.000
B38 Coccidioidomycosis
0.648 0.352 0.000
H66.1 Chronic tubotympanic suppurative otitis media
0.648 0.352 0.000
H40.5 Glaucoma secondary to other eye disorders
0.647 0.353 0.000
Z45.9 Adjustment and management of unspecified implanted device
0.647 0.353 0.000
Z45.3 Adjustment and management of implanted hearing device
0.647 0.353 0.000
A02 Other Salmonella infections
0.646 0.353 0.000
D47.4 Osteomyelofibrosis
0.646 0.354 0.000
W19.4 Street and highway
0.646 0.354 0.000
W13 Fall from, out of or through building or structure
0.646 0.354 0.000
W10 Fall on and from stairs and steps
0.644 0.356 0.000
X50-X57 Overexertion, travel and privation
0.643 0.357 0.000
L00-L08 Infections of the skin and subcutaneous tissue
0.643 0.357 0.000
C25 Malignant neoplasm of pancreas
0.642 0.358 0.000
Y59 Other and unspecified vaccines and biological substances
0.641 0.359 0.000
Y58 Bacterial vaccines
0.641 0.359 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.641 0.359 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.641 0.359 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.641 0.359 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.641 0.359 0.000
Z71.7 Human immunodeficiency virus [HIV] counselling
0.640 0.360 0.000
Z71.5 Drug abuse counselling and surveillance
0.640 0.360 0.000
Z71.4 Alcohol abuse counselling and surveillance
0.640 0.360 0.000
Z71.0 Person consulting on behalf of another person
0.640 0.360 0.000
A44 Bartonellosis
0.640 0.360 0.000
A43 Nocardiosis
0.640 0.360 0.000
A42 Actinomycosis
0.640 0.360 0.000
A37 Whooping cough
0.640 0.360 0.000
A36 Diphtheria
0.640 0.360 0.000
A32 Listeriosis
0.640 0.360 0.000
A31 Infection due to other mycobacteria
0.640 0.360 0.000
A30 Leprosy [Hansen's disease]
0.640 0.360 0.000
A38 Scarlet fever
0.640 0.360 0.000
A35 Other tetanus
0.640 0.360 0.000
A34 Obstetrical tetanus
0.640 0.360 0.000
A33 Tetanus neonatorum
0.640 0.360 0.000
A04.6 Enteritis due to Yersinia enterocolitica
0.640 0.360 0.000
A04.4 Other intestinal Escherichia coli infections
0.640 0.360 0.000
A04.3 Enterohaemorrhagic Escherichia coli infection
0.640 0.360 0.000
A04.2 Enteroinvasive Escherichia coli infection
0.640 0.360 0.000
A04.1 Enterotoxigenic Escherichia coli infection
0.640 0.360 0.000
A04.0 Enteropathogenic Escherichia coli infection
0.640 0.360 0.000
Q63 Other congenital malformations of kidney
0.639 0.361 0.000
Z45.8 Adjustment and management of other implanted devices
0.638 0.362 0.000
Z31 Procreative management
0.637 0.363 0.000
Q87 Other specified congenital malformation syndromes affecting multiple systems
0.636 0.364 0.000
Q66 Congenital deformities of feet
0.636 0.364 0.000
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere
0.635 0.365 0.000
H68 Eustachian salpingitis and obstruction
0.635 0.365 0.000
H67 Otitis media in diseases classified elsewhere
0.635 0.365 0.000
B49 Unspecified mycosis
0.635 0.365 0.000
W50-W64 Exposure to animate mechanical forces
0.635 0.365 0.000
O20-O29 Other maternal disorders predominantly related to pregnancy
0.634 0.366 0.000
Z46 Fitting and adjustment of other devices
0.632 0.368 0.000
X49 Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
0.632 0.368 0.000
B90-B94 Sequelae of infectious and parasitic diseases
0.630 0.369 0.000
H72.8 Other perforations of tympanic membrane
0.630 0.370 0.000
D44.3 Pituitary gland
0.630 0.370 0.000
H74.9 Disorder of middle ear and mastoid, unspecified
0.629 0.371 0.000
Q24 Other congenital malformations of heart
0.629 0.371 0.000
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
0.628 0.371 0.000
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.628 0.371 0.000
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]
0.628 0.371 0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour
0.628 0.371 0.000
Z35.0 Supervision of pregnancy with history of infertility
0.628 0.372 0.000
H66.2 Chronic atticoantral suppurative otitis media
0.628 0.372 0.000
H66.0 Acute suppurative otitis media
0.628 0.372 0.000
Y45.5 4-Aminophenol derivatives
0.627 0.373 0.000
D46.9 Myelodysplastic syndrome, unspecified
0.627 0.373 0.000
C92 Myeloid leukaemia
0.625 0.375 0.000
X42 Accidental poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
0.625 0.375 0.000
Z35.5 Supervision of elderly primigravida
0.625 0.375 0.000
C05 Malignant neoplasm of palate
0.624 0.376 0.000
Q54 Hypospadias
0.623 0.377 0.000
Z71.2 Person consulting for explanation of investigation findings
0.623 0.377 0.000
Z40.9 Prophylactic surgery, unspecified
0.622 0.377 0.000
Z74 Problems related to care-provider dependency
0.622 0.378 0.000
Q79 Congenital malformations of musculoskeletal system, not elsewhere classified
0.622 0.378 0.000
C32.1 Supraglottis
0.621 0.378 0.000
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system
0.621 0.379 0.000
B44 Aspergillosis
0.621 0.379 0.000
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified
0.621 0.379 0.000
C90.2 Plasmacytoma, extramedullary
0.620 0.380 0.000
Z45.1 Adjustment and management of infusion pump
0.620 0.380 0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.618 0.382 0.000
Y45.4 Antirheumatics
0.618 0.382 0.000
Y45.2 Propionic acid derivatives
0.618 0.382 0.000
D05.0 Lobular carcinoma in situ
0.618 0.382 0.000
Z40.8 Other prophylactic surgery
0.618 0.382 0.000
W03 Other fall on same level due to collision with, or pushing by, another person
0.617 0.383 0.000
L89.9 Decubitus ulcer and pressure area, unspecified
0.617 0.383 0.000
C83.0 Small cell (diffuse)
0.616 0.384 0.000
D76 Certain diseases involving lymphoreticular tissue and reticulohistiocytic system
0.616 0.384 0.000
Z32.9 Pregnancy confirmed (erroneous code. See Z321)
0.616 0.384 0.000
A49.3 Mycoplasma infection, unspecified
0.615 0.385 0.000
A49.2 Haemophilus influenzae infection, unspecified
0.615 0.385 0.000
C34.8 Overlapping lesion of bronchus and lung
0.614 0.385 0.000
C91.4 Hairy-cell leukaemia
0.614 0.386 0.000
Q65 Congenital deformities of hip
0.613 0.386 0.000
Q50.6 Other congenital malformatons of Fallopian tube and broad ligament
0.612 0.388 0.000
Q50.5 Embryonic cyst of broad ligament
0.612 0.388 0.000
Q50.3 Other congenital malformations of ovary
0.612 0.388 0.000
Q50.2 Congenital torsion of ovary
0.612 0.388 0.000
Q50.1 Developmental ovarian cyst
0.612 0.388 0.000
Q50.0 Congenital absence of ovary
0.612 0.388 0.000
B37.7 Candidal septicaemia
0.612 0.388 0.000
B37.6 Candidal endocarditis
0.612 0.388 0.000
B37.5 Candidal meningitis
0.612 0.388 0.000
B37.4 Candidiasis of other urogenital sites
0.612 0.388 0.000
U82-U85 Resistance to antimicrobial and antineoplastic drugs
0.611 0.389 0.000
W19.2 School, other institution and public administrative area
0.611 0.389 0.000
W11 Fall on and from ladder
0.610 0.389 0.000
C02 Malignant neoplasm of other and unspecified parts of tongue
0.610 0.390 0.000
D60-D64 Aplastic and other anaemias
0.609 0.391 0.000
G30-G32 Other degenerative diseases of the nervous system
0.608 0.392 0.000
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites
0.607 0.392 0.000
Z35.8 Supervision of other high-risk pregnancies
0.607 0.393 0.000
H55 Nystagmus and other irregular eye movements
0.607 0.393 0.000
Y49.5 Other antipsychotics and neuroleptics
0.607 0.393 0.000
Y43.4 Immunosuppressive agents
0.606 0.394 0.000
Z34.0 Supervision of normal first pregnancy
0.606 0.394 0.000
O00 Ectopic pregnancy
0.606 0.394 0.000
H42 Glaucoma in diseases classified elsewhere
0.606 0.394 0.000
A63 Other predominantly sexually transmitted diseases, not elsewhere classified
0.605 0.395 0.000
Z73.6 Limitation of activities due to disability
0.605 0.395 0.000
Z73.5 Social role conflict, not elsewhere classified
0.605 0.395 0.000
Z73.4 Inadequate social skills, not elsewhere classified
0.605 0.395 0.000
Z73.2 Lack of relaxation and leisure
0.605 0.395 0.000
Z73.1 Accentuation of personality traits
0.605 0.395 0.000
Z73.0 Burn-out
0.605 0.395 0.000
C32.8 Overlapping lesion of larynx
0.604 0.396 0.000
C32.3 Laryngeal cartilage
0.604 0.396 0.000
C32.2 Subglottis
0.604 0.396 0.000
Y54.4 Loop [high-ceiling] diuretics
0.604 0.396 0.000
W17 Other fall from one level to another
0.604 0.396 0.000
W16 Diving or jumping into water causing injury other than drowning or submersion
0.604 0.396 0.000
W15 Fall from cliff
0.604 0.396 0.000
W14 Fall from tree
0.604 0.396 0.000
W12 Fall on and from scaffolding
0.604 0.396 0.000
W09 Fall involving playground equipment
0.604 0.396 0.000
W05 Fall involving wheelchair
0.604 0.396 0.000
W04 Fall while being carried or supported by other persons
0.604 0.396 0.000
W01 Fall on same level from slipping, tripping and stumbling
0.604 0.396 0.000
W00 Fall on same level involving ice and snow
0.604 0.396 0.000
Z52 Donors of organs and tissues
0.602 0.397 0.000
D73 Diseases of spleen
0.602 0.397 0.000
Y44 Agents primarily affecting blood constituents
0.602 0.397 0.000
H40.6 Glaucoma secondary to drugs
0.602 0.397 0.000
H40.3 Glaucoma secondary to eye trauma
0.602 0.397 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.601 0.399 0.000
Z35.4 Supervision of pregnancy with grand multiparity
0.600 0.400 0.000
A48 Other bacterial diseases, not elsewhere classified
0.599 0.400 0.000
Y43.9 Primarily systemic agent, unspecified
0.598 0.402 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.598 0.402 0.000
Y43.6 Enzymes, not elsewhere classified
0.598 0.402 0.000
Y43.5 Acidifying and alkalising agents
0.598 0.402 0.000
Y43.2 Antineoplastic natural products
0.598 0.402 0.000
D48.7 Other specified sites
0.597 0.402 0.000
A04.5 Campylobacter enteritis
0.596 0.404 0.000
Q27 Other congenital malformations of peripheral vascular system
0.596 0.404 0.000
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified
0.596 0.404 0.000
D48.4 Peritoneum
0.596 0.404 0.000
D48.3 Retroperitoneum
0.596 0.404 0.000
D48.2 Peripheral nerves and autonomic nervous system
0.596 0.404 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.